Physician

Joel Michael Hartman, MD

According to 2025 Medicare claims, Joel Hartman, MD (NPI: 1184606147) practices allergy/immunology in the Winston-Salem, NC market, with the plurality of this provider's patient population coming from Forsyth, NC. This provider's primary affiliated billing organization is ALLERGY PARTNERS, PLLC (NPI: 1558351726; TIN: 561249571) and primary practice location at 27103-2932. Hartman is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033) and CVS ACO (ACO ID: A5407), participating under the MSSP model.

Hartman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 281 traditional Medicare patients, billed 19,517 HCPCS/CPT codes, and received $371,579 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,886 prescription claims across 299 beneficiaries totaling $1,011,748 in drug costs, led by Dupixent Syringe (Dupilumab). DME data shows 74 claims. Open Payments data shows 264 records totaling $177,493. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $40,520 to $371,579. Similarly, Part D prescription costs have moved sharply higher in recent years, from $86,342 to $1,011,748. In contrast, DME billing represents a smaller volume and declined steadily, from $1,297 to $312.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$186K$372K2015 Medicare payment: $40,520 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $49,066 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $61,281 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $50,722 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $114,240 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $206,483 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $277,816 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $238,046 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $362,334 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $371,579 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152504,816$40,520
20162905,343$49,066
20173116,878$61,281
20182995,255$50,722
20193196,914$114,240
20203077,844$206,483
202130012,218$277,816
202229011,190$238,046
202329916,045$362,334
202428119,517$371,579

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$510K$1.0M2015 Drug cost: $86,342 (USD; Tot_Drug_Cst)2016 Drug cost: $91,045 (USD; Tot_Drug_Cst)2017 Drug cost: $103,429 (USD; Tot_Drug_Cst)2018 Drug cost: $100,876 (USD; Tot_Drug_Cst)2019 Drug cost: $266,907 (USD; Tot_Drug_Cst)2020 Drug cost: $528,787 (USD; Tot_Drug_Cst)2021 Drug cost: $592,995 (USD; Tot_Drug_Cst)2022 Drug cost: $704,221 (USD; Tot_Drug_Cst)2023 Drug cost: $1,020,119 (USD; Tot_Drug_Cst)2024 Drug cost: $1,011,748 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015160748$86,342
2016178940$91,045
20171961,218$103,429
20181971,072$100,876
20192341,307$266,907
20202051,408$528,787
20212401,442$592,995
20222571,475$704,221
20232931,976$1,020,119
20242991,886$1,011,748

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$80K$159K2015 Medicare payment: $41,311 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $92,704 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $67,674 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $59,392 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $65,577 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $153,638 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $154,566 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $159,151 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $130,926 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $123,776 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R34$41,311
2016N/R78$92,704
2017N/R105$67,674
2018N/R101$59,392
2019N/R104$65,577
2020N/R153$153,638
2021N/R104$154,566
2022N/R120$159,151
2023N/R76$130,926
2024N/R74$123,776

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more4444$113
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more87119$87
95117Professional service for multiple injections of allergen103476$8
95115Professional service for single injection of allergen52217$7
96160Administration and interpretation of patient-focused health risk assessment92187$2

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent SyringeDupilumab34924$144,744
TezspireTezepelumab-Ekko33924$136,163
NucalaMepolizumab24672$99,848
XolairOmalizumab421,176$93,212
CuvitruImmun Glob G(Igg)/Gly/Iga Ov5013364$91,911

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J1555Injection, immune globulin (cuvitru), 100 mgNN/R13$53,561
J1561Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mgNN/R13$43,142
J1559Injection, immune globulin (hizentra), 100 mgNN/R11$22,857
Q2052Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)NN/R12$3,956
K0552Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, eachNN/R25$260

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.264$177,493AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Joel Michael Hartman, MD?

Tedicare shows public-source Medicare data for Joel Michael Hartman, MD (NPI 1184606147), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joel Michael Hartman, MD have ACO affiliation data?

Joel Michael Hartman, MD is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033) and CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Joel Michael Hartman, MD?

Joel Michael Hartman, MD is linked to ALLERGY PARTNERS, PLLC (billing NPI 1558351726) in the available physician profile data.

Does Joel Michael Hartman, MD have Open Payments data?

Joel Michael Hartman, MD has 264 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.